Regulations, such as EU 2016/161, which has to be implemented by Feb. 9, 2019, require innovative solutions to protect patients against falsified medicines. A newly developed label, from Schreiner MediPharm, demonstrates a combination of diverse digital security features on a booklet-label with an integrated first-opening seal.
The bottom layer of the label contains a tab that serves as a closure seal for tampering protection. When the seal is opened, a void effect emerges as an irreversible first-opening indication. The booklet-label applied to a medicine pack allows a pharmacist to view product information about the medication without opening the pack and thus destroying the tamper protection. In addition, the sample label is equipped with three digital security features.